Back to Search Start Over

Heart infarct as the major cause of death of hematological patients as identified by autopsy

Authors :
Barbara Górnicka
Łukasz Koperski
Anna Kamińska
Anna Waszczuk-Gajda
Joanna Drozd-Sokołowska
Zbigniew Lewandowski
Aleksander Wasiutyński
Wiesław Wiktor Jędrzejczak
Michal F. Kaminski
Source :
Advances in Clinical and Experimental Medicine. 27:63-70
Publication Year :
2018
Publisher :
Wroclaw Medical University, 2018.

Abstract

Background Despite progress in diagnostic procedures, clinical diagnosis is not always confirmed by an autopsy. An autopsy is a valuable tool in evaluating diagnostic accuracy. Objectives The aim of the study was to compare clinical diagnoses of immediate causes of death with autopsy findings in patients with hematological malignancies or aplastic anemia. Material and methods In this study, the results of 154 autopsies (1993-2004) of patients with hematological diseases were reviewed and compared with clinical data. The most probable causes of death in the case of particular hematological diseases as well as the discordances between clinical and autopsy diagnoses and their relation to the clinical characteristic were identified in the studied cohort, which primarily included patients whose death at that particular time was not explained by the clinical course, and in 50% of cases was sudden. Results Although various combined infections have been found to be responsible for the largest number of deaths (26.6%), the most common single cause was myocardial infarction (29 patients, 18.8%). The discordance between clinical and post-mortem diagnoses of immediate causes of death was found in 55 patients (35.7%; 95% CI 28.2-42.8%), with 50.9% of cases considered class I discrepancies according to Goldman's criteria. The myocardial infarction was found to be clinically undiagnosed in 69% of cases. In 41% of cases, it was a class I discrepant diagnosis. Conclusions This data suggests that hematological patients require special attention and probably preventive measures concerning coronary heart disease, particularly during the initiation of antineoplastic therapy.

Details

ISSN :
18995276
Volume :
27
Database :
OpenAIRE
Journal :
Advances in Clinical and Experimental Medicine
Accession number :
edsair.doi.dedup.....9f726e1c64f764952daf850f1e0a4558
Full Text :
https://doi.org/10.17219/acem/65866